Preclinical evaluation and first-in-human phase 1 trial of AZD0186, a novel, oral small molecule glucagon-like peptide-1 receptor agonist.

AZD0186：新型口服小分子 glucagon-like peptide-1 受體促效劑的臨床前評估與首次人體第一期試驗